The elevated levels of CCL3 and CCL4 are a signature hallmark in activated B-cell-like (ABC) DLBCL, as a category of DLBCL, and are a clear predictor of poor prognosis (Takahashi et al., 2015). Here, CCL4 is linked to diffuse large B-cell lymphoma.